Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties.

Yip NC, Fombon IS, Liu P, Brown S, Kannappan V, Armesilla AL, Xu B, Cassidy J, Darling JL, Wang W. · 2011

Read Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties. by Yip NC, Fombon IS, Liu P, Brown S, Kannappan V, Armesilla AL, Xu B, Cassidy J, Darling JL, Wang W. (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3101904.txt.

Description

Yip and coauthors reported in 2011 that disulfiram, a decades old drug used to deter drinking, kills breast cancer cells and their hardiest stem like cells when paired with copper. Drug resistance, blamed largely on cancer stem cells, is the main reason breast chemotherapy fails. In dishes, the drug plus copper killed standard breast cancer lines at low doses and sharply boosted a common chemotherapy drug's power, with a true synergistic pattern.

The combination generated corrosive oxygen molecules and switched on stress death pathways inside the cells. At the same time it shut down a survival factor that resistant cancers keep permanently active and that chemotherapy itself can provoke. Sphere forming growth and stem cell marker populations, the stand ins for cancer stem cells, both fell after a day of exposure. The authors propose repurposing this cheap, known drug as a resistance breaker, pending animal and clinical tests.

Catalog record

CREATORYip NC, Fombon IS, Liu P, Brown S, Kannappan V, Armesilla AL, Xu B, Cassidy J, Darling JL, Wang W.
YEAR2011
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3101904

Browse the full library · About the Tower of Babel